Tideglusib for treating congenital or childhood onset myotonic dystrophy [ID3915]

Status:

Awaiting development

Technology type:

Medicine

Decision:

None selected

Process:

STA Standard

ID number:

3915

Email enquiries

If you have any queries please email scheduling@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual